Nachrichten



23. Mai 2016
Bayer Kultur stellt Saisonprogramm vor

Glanzvoll in die Spielzeit 2016/17 mehr


23. Mai 2016
Integrierte und innovative Lösungen für die Landwirtschaft der nächsten Generation:

Bayer will durch Übernahme von Monsanto ein weltweit führendes Unternehmen der Agrarwirtschaft werden mehr


Nachrichtenüberblick

Videos

Video Übersicht

Social Media

Facebook

Bayer   Sustainability: Part of Our Corporate Strategy

To Bayer, sustainability basically means future viability and it forms an integral part of our business strategy. We are convinced that we can only achieve lasting commercial success if we balance economic growth with ecological and social responsibility.

Learn more:
http://www.bayer.com/en/sustainabilitystrategy.aspx
24. Mai 2016
Bayer   Today we're announcing an offer to acquire Monsanto which would create a global agriculture leader. Combined, we would be an innovation powerhouse -- delivering integrated solutions for the next generation of farming. Get updates and additional information on how we're advancing agriculture together. www.advancingtogether.com

Forward-Looking Statements
This communication may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Additional Information This communication relates to a proposed offer by Bayer Aktiengesellschaft or its subsidiaries (“Bayer”), to purchase all of the outstanding shares of common stock, par value $0.01 per share, of Monsanto Company, a Delaware corporation (“Monsanto”). This communication is neither an offer to purchase nor a solicitation of an offer to sell shares of Monsanto. No tender offer for the shares of Monsanto has commenced at this time. At the time a tender offer for the shares of Monsanto is commenced, Bayer will file tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other offer documents) with the Securities and Exchange Commission (the “SEC”) with respect to the tender offer. Any definitive tender offer documents will be mailed to the stockholders of Monsanto. STOCKHOLDERS OF MONSANTO ARE URGED TO READ THE RELEVANT TENDER OFFER MATERIALS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TENDER OFFER THAT STOCKHOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING THE TENDER OF THEIR SHARES. Stockholders of Monsanto will be able to obtain free copies of these documents (if and when available) and other documents filed by Bayer with the SEC through the website maintained by the SEC at www.sec.gov.
23. Mai 2016
Bayer   "Let’s create a better life together!"
Volunteers from Bayer Ukraine and “Ukrainian Creative Reformers” joined forces to create an inspiring environment for the community in Tsentralne village, Ukraine.
20. Mai 2016
Bayer   The Protein Engineers
Interdisciplinary Bayer Teams Accelerating Life Science Research

Bayer scientists are working in interdisciplinary teams to search for new targets for active substances or diagnostic options. Synergies in medical and crop protection research result in completely new approaches, from the design of therapeutic antibodies to improved production of new crop protection products. One key to success is highly effective protein molecules, ­constructed in Bayer’s laboratories by protein engineers.

Learn more:
http://www.research.bayer.com/en/nimbus.aspx
18. Mai 2016
Bayer   A New Factor

New Therapeutic Approaches to Thrombosis through Genome Research

Research in the lab and on the computer: researchers at Bayer are collaborating closely in an interdisciplinary team to develop new options in thrombosis treatment. One new approach they are looking at is blood coagulation factor XI.

Learn more:
http://www.research.bayer.com/en/genome-research-into-thrombosis.aspx
17. Mai 2016

Twitter

Bayer   #Bayer & Monsanto's combined R&D pipeline would advance #farming together https://t.co/zFRZrCDvU7 #AdvancingTogether https://t.co/v5RosMQssN24. Mai 2016
Bayer   Our goal: to generate #economic, #ecological & #social benefit through the integration of #sustainability. https://t.co/oPb9Og01Le24. Mai 2016
Bayer   To Bayer, #sustainability basically means future viability and it forms an integral part of our business #strategy. https://t.co/AJuG0Sulrh24. Mai 2016
Bayer   From seeds & traits to #digitalfarming, Bayer's offer would create value. https://t.co/zFRZrCDvU7 #AdvancingTogether https://t.co/daXyssoUW724. Mai 2016
Bayer   Watch Bayer #CEO Werner Baumann discuss #Bayer’s offer to acquire #Monsanto:
https://t.co/zFRZrCDvU7
#AdvancingTogether
23. Mai 2016

Apps

„Farming’s Future“-Magazin

Sichere Ernährung, umweltverträgliche Landwirtschaft – rund um den Globus! Das „Farming’s Future“-Magazin zeigt die vielen Seiten der Agrarwirtschaft mit Infografiken, Animationen und Videos. Laden Sie sich die App für Ihr iPad oder Android Tablet herunter.

mehr

Publikationen

Zwischenbericht 1. Quartal 2016

Bayer startet erfolgreich ins neue Geschäftsjahr. Alle Fakten finden Sie im aktuellen Quartalsbericht.

mehr
Letzte Änderung: 23. Mai 2016 Copyright © Bayer AG
http://www.bayer.de